Background: A fine balance exists between the early treatment of a potentially lethal prostate disease and possible complications from indolent disease. Prostate-specific antigen (PSA) is an indicator progression used in clinical staging cancer (PCa). Given arsenal methods available, some intrusive, not, there future for biochemical staging? As presence stage are influenced by multiple factors,...
